<DOC>
	<DOCNO>NCT01815138</DOCNO>
	<brief_summary>This prospective randomize double blind study involve patient high risk OHSS development peak serum E2 level &lt; 4,000 pg/ml compare ongoing pregnancy rate patient receive adjuvant hCG 1,000 IU time GnRH agonist trigger adjuvant hCG 1,500 IU 35 hour GnRH agonist trigger .</brief_summary>
	<brief_title>Co-administration Low Dose hCG Time GnRH Agonist Trigger 35 Hours Later Prevention OHSS</brief_title>
	<detailed_description>Ovarian hyperstimulation syndrome ( OHSS ) iatrogenic complication control ovarian hyperstimulation may result significant morbidity rarely mortality well significant financial psychological distress . GnRH agonist trigger show effective OHSS prevention . However , adoption use widely accept view concern regard potential impairment implantation . Intensive luteal phase supplementation estrogen ( E2 ) progesterone ( P ) important due strong evidence abnormal luteal phase serum E2 P profile . However , show optimal conception rate achieve high risk patient peak serum E2 &lt; 4,000 pg/ml despite aggressive steroidal supplementation . It propose use adjuvant low dose hCG time GnRH agonist trigger 35 hour later rescue corpus lutea help improve corpus lutea function improve pregnancy rate . The study evaluate patient high risk OHSS development peak serum E2 &lt; 4,000 pg/mL determine whether time low dose hCG administration affect ongoing pregnancy rate risk OHSS . Markers corpus luteum function serum 17 hydroxy-progesterone prorenin luteal phase early pregnancy help elucidate effect adjuvant low dose hCG GnRH agonist trigger corpus luteum function .</detailed_description>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<criteria>Normal baseline serum follicle stimulate hormone , polycystic ovarian syndrome ( PCOS ) , Polycystic ovarian morphology , Previous high responder previous OHSS , must &gt; 14 follicle 11 mm diameter peak serum E2 level &lt; 4,000 pg/mL day trigger oocyte maturation . Hypothalamic dysfunction , Patients &lt; 14 follicle &lt; 11 mm diameter , peak serum E2 level &gt; = 4,000 pg/mL .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>OHSS , GnRH agonist trigger , low dose hCG , PCOS , IVF</keyword>
</DOC>